Agilent Systems launches AssayMAP Bravo for proteins purification Agilent Technologies Inc.

Related StoriesPresident and CEO of Proteins Sciences elected as 2015 Fellow of the International Society for VaccinesStudy reveals system behind protein-related diseasesUnderstanding how schizophrenia affects workings of the brain’This launch gives a complete remedy for a number of sample prep applications and will save valuable time developing and validating assays, allowing customers to focus on generating business-vital data to advance their biologics pipeline,’ stated Nitin Sood, general manager of Agilent’s Automation Solutions Division. ‘The AssayMAP Bravo and cartridges for proteins purification are ideal for those in biologics discovery and development who need streamlined, exact purification of their proteins of interest.’ The Bravo for Protein Purification uses disposable, 5-microliter packed-bed AssayMAP cartridges in a 96-channel microplate format, which decreases the quantity of starting sample utilized and speeds period to results.In an assessment of many studies, researchers discovered that women with breasts cancers who had low vitamin D levels had a more than doubled threat of their cancer coming back, and an nearly doubled risk of death compared to females with high supplement D amounts, adds the Supplement D Council. A 2012 research out of Belgium, for example, found that women diagnosed with early breast tumor developed larger tumors when their vitamin D levels were low compared to other diagnosed women with high degrees of vitamin D.